Cargando…
Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness
BACKGROUND: Multiple myeloma (MM) is the second most common hematological cancer worldwide and has significant morbidity and mortality and is increasing in incidence. While MM management costs are considerable, specific economic data at the country level remain scarce. OBJECTIVE: This study assesses...
Autores principales: | Neves, Manuel, Trigo, Fernanda, Rui, Bergantim, João, Cristina, Lúcio, Paulo, Mariana, Neves, Mendes, João, Pedrosa, Hugo, Geraldes, Catarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079298/ https://www.ncbi.nlm.nih.gov/pubmed/33517511 http://dx.doi.org/10.1007/s40273-020-00993-5 |
Ejemplares similares
-
Burden of Disease and Cost of Illness of Inflammatory Bowel Diseases in Portugal
por: Magro, Fernando, et al.
Publicado: (2022) -
PB2162: EVALUATION OF IMMUNE RECONSTITUTION IN MULTIPLE MYELOMA PATIENTS ON MAINTENANCE THERAPY WITH LENALIDOMIDE - THE ROLE OF HEAVYLITE CHAINS
por: Miranda, Mariana, et al.
Publicado: (2023) -
Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy
por: Guimarães, Cristina, et al.
Publicado: (2012) -
Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
por: Bergantim, Rui, et al.
Publicado: (2012) -
Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study
por: Labisa, Pedro, et al.
Publicado: (2021)